UK Osteoporosis Market Analysis

$3,000.00$7,500.00

  • Type: Common Disease Area
  • Published : April 2021
  • Region: Europe
  • Country: UK
  • Report ID : 2622

  • Format: PPT, PDF

UK Osteoporosis Drugs Market: Segmented by Drug Class (Bisphosphonates, Selective Estrogen Inhibitors Modulator, Parathyroid Hormone Therapy, Calcitonin, Rank Ligand Inhibitors and Others) and Route of Administration (Oral, Injectable and Others) – Growth, Trends, and Forecasts (2019 – 2028)

Clear
SKU: 2622 Categories: ,

Report Overview

The UK Osteoporosis Drugs Market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Osteoporosis is defined as a medical condition, which is characterized by low density and quality of bones in humans. Furthermore, the bones become porous in this medical condition, which makes them more fragile and, in turn, prone to factures. The condition is caused by over production of the hormone called as parathyroid. The condition can lead to severe fractures, which can have deleterious effects on the health of patient. Therefore, the condition requires treatment, which includes the use of osteoporosis drugs. Some of the drugs available in the market include bisphosphonates selective estrogen inhibitors modulator (SERM), parathyroid hormone therapy, calcitonin, and RANK ligand inhibitors.

The market is largely driven by a significant rise in the prevalence of this disorder globally. This unprecedented rise in the prevalence resulted in the high demand for drugs in prophylaxis and treatment of osteoporosis thus widening the growth potential over the coming years. Moreover, the geriatric population possessing high susceptibility for osteoporosis is further presumed to propel the high demand. High R&D investment, fusions, and acquisitions, and drug development agreements are the other strategies incorporated.

Market Drivers

There has been a noticeable growth in people around the country in the awareness of osteoporosis, which is a noticeable factor in the osteoporosis market. This recognition is primarily a result of numerous steps implemented across different programs and campaigns by public and private associations. Moreover, according to National Institutes of Health Osteoporosis and Related Bone Diseases, lifestyle associated factors such as alcohol abuse, sedentary lifestyle, smoking is found to promote this condition in men. The factor poses the high clinical urgency to curb osteoporosis, thus predicted to further bolster the overall growth. The rapid increase in the prevalence of osteoporosis in postmenopausal women, growing awareness about osteoporotic care and increasing investment in drug discovery and development are the major factors expected to drive the growth of the market. Rising aging population and post-menopausal women, growing prevalent cases of osteoporosis in younger population, increase expenditures in R&D for new and innovative drug formulation are the other factors supplementing the growth of osteoporosis drugs market.

1. UK Osteoporosis Drugs Market Overview………………………………………………
A. Market Size
2. Market Growth Drivers…………………………………………………………………
A. R&D spending by the prominent players and their attempts to market branded and generic medicine at a reasonably low price
B. Growing awareness of osteoporosis among people, rapid increase in the prevalence of osteoporosis in postmenopausal women and rising aging population
3. Osteoporosis Disease Classification………………………………………………
A. Primary osteoporosis
I. Postmenopausal osteoporosis (Type I)
II. Senile osteoporosis (Type II)
B. Secondary osteoporosis
4. UK Osteoporosis Drugs Market Segmentation………………………………………
A. By Drug Class
I. Bisphosphonates
II. Selective estrogen inhibitors modulator (SERM)
III. Parathyroid hormone therapy
IV. Calcitonin
V. Rank ligand inhibitors
VI. Others
B. By Route of Administration
I. Oral
II. Injectable
III. Others
5. Osteoporosis Drugs Major Products Market Share…………………………….
A. Key Findings
B. Market Analysis, Insights and Forecast – By Drug Type
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. F. Hoffmann-La Roche Ltd. Company overview, Product & Services, Strategies & Financials
B. GlaxoSmithKline PLC (GSK) Company overview, Product & Services, Strategies & Financials
C. Merck & Co. Inc. Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………
A. New Trends and Development of Osteoporosis Drugs market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Class:

On the basis of drug class, the market is segmented into bisphosphonates, selective estrogen inhibitors modulator (SERM), parathyroid hormone therapy, calcitonin, rank ligand inhibitors, and others. The bisphosphonates acquired the major share of osteoporosis drugs market in 2018, owing to increase in investment in R&D of advanced novel bisphosphonates drugs by major players. Furthermore, bisphosphonates are commonly prescribed drugs for the treatment of osteoporosis, which boosts the growth of the market.  However, the rank ligand inhibitors segment is expected to exhibit fastest growth rate during the forecast period, because these drugs are used to treat bone metastasis by acting as a chemoattractant to bone for tumor cells that express its receptor, RANK. Thus, the inhibition of the RANKL-RANK pathway serves as an ideal treatment for the bone metastasis.

By Route of Administration:

By route of administration, it is segregated into oral, injectable, and others. The oral segment acquired the major share of the osteoporosis drugs market, owing to abundant availability of medications, which are available as oral drugs in the market. Conversely, the injectable segment is expected to grow at the fastest CAGR during the forecast period, owing to factors such as rise in need for drugs, which exhibit improved bioavailability rapid mode of action.

Top 5 Major Players

The UK osteoporosis drugs market is highly competitive, and the prominent players in the market have adopted various strategies to garner maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Amgen Inc., F. Hoffmann-La Roche AG, Radius Health, Inc., Merck & Co. Inc., Novartis International AG (Sandoz), Pfizer Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements